64 results
8-K
EX-1.1
VBIV
VBI Vaccines Inc.
6 Jul 23
VBI Vaccines Announces Proposed Concurrent Public Offering and Registered Direct Offering of Common Shares and Warrants
6:47pm
Shares upon exercise of options, restricted stock units or similar equity securities, pursuant to any options, share bonus or other share plan
8-K
VBIV
VBI Vaccines Inc.
4 Apr 23
VBI Vaccines Announces Increased Focus on Hepatitis B, Organizational Changes, and Reverse Stock Split
8:00am
for an annual bonus in an amount up to forty-five percent (45%) of her then applicable base salary, based upon the achievement of certain performance
8-K
EX-10.1
y50zgu1rrd6f6y
4 Apr 23
VBI Vaccines Announces Increased Focus on Hepatitis B, Organizational Changes, and Reverse Stock Split
8:00am
8-K
EX-10.1
hfgfnl3e7wb
15 Sep 22
VBI Vaccines Secures $100 Million Debt Facility From K2 HealthVentures
5:01pm
8-K
EX-10.1
hs8byj7a
27 May 20
VBI Vaccines Secures $50 Million Debt Financing From K2 HealthVentures
5:15pm
8-K
EX-1.1
wrh1zehz9a0g55 oz
24 Apr 20
VBI Vaccines Announces Proposed Public Offering of Common Shares
6:16am
8-K
EX-1.1
1fx2kbu
20 Sep 19
VBI Vaccines Announces Proposed Public Offering of Common Shares
5:27pm